THE PROPHYLAXIS OF VERTEBRAL COMPRESSION REFRACTURES USING ZOLEDRONIC ACID

A. Yu. Kochish , S. N. Ivanov , V. N. Khrulev

Traumatology and Orthopedics of Russia ›› 2010, Vol. 16 ›› Issue (2) : 113 -115.

PDF
Traumatology and Orthopedics of Russia ›› 2010, Vol. 16 ›› Issue (2) : 113 -115. DOI: 10.21823/2311-2905-2010-0-2-113-115
MATERIALS OF THE SCIENTIFIC AND PRACTICAL CONFERENCE
other

THE PROPHYLAXIS OF VERTEBRAL COMPRESSION REFRACTURES USING ZOLEDRONIC ACID

Author information +
History +
PDF

Abstract

29 women with postmenopausal osteoporosis, complicated by compression vertebral fractures were treated by infusion of zoledronic acid, 5 mg. The results were assessed using dual-energy X-ray absorptiometry. By 12 months BMD increased both in lumbar spine (mean 5,2% (σ=0,17) and in femoral neck (mean 3,9% (σ=0,20)); by 24 month the mean increase were 6,3% и 4,0% (σ=0,33) respectively. No new compression vertebral fractures were found.

Keywords

vertebral compression fractures / zoledronic acid

Cite this article

Download citation ▾
A. Yu. Kochish, S. N. Ivanov, V. N. Khrulev. THE PROPHYLAXIS OF VERTEBRAL COMPRESSION REFRACTURES USING ZOLEDRONIC ACID. Traumatology and Orthopedics of Russia, 2010, 16(2): 113-115 DOI:10.21823/2311-2905-2010-0-2-113-115

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

1. Евстегнеева Л.П. Эпидемиология остеопоротических переломов позвоночника по данным рентгено-морфометрического анализа среди популяционной выборки жителей г. Екатеринбурга 50 лет и старше/Л.П. Евстегнеева, О.М. Лесняк, А.И. Пивень//Остеопороз и остеопатии. -2001. -№ 2. -С. 2-6.

[2]

2. Клинические рекомендации. Остеопороз. Диагностика, профилактика и лечение/под ред. О.М. Лесняк, Л.И. Беневоленской. -2-е изд. -М.: ГЭОТАР-Медиа, 2009. -272 с.

[3]

3. Лесняк О.М. Эпидемиология переломов позвоночника и периферических костей в старших возрастных группах жителей г. Екатеринбурга/О.М. Лесняк [и др.]//Остеопороз и остеопатии. -1999. -№2. -С. 2-4.

[4]

4. Михайлов Е.Е. Распространенность переломов позвоночника в популяционной выборке лиц 50 лет и старше/Е.Е. Михайлов, Л.И. Беневоленская, Н.М. Мылов//Вестник травматологии и ортопедии им. Н.Н. Приорова. -1997. -№ 3. -С. 20-27.

[5]

5. Black D.M. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis/D.M. Black [et al.]//New Engl. J. Med. -2007. -Vol. 18, N356. -P. 1809-1822.

[6]

6. Brown J.P. 2002 clinical practice guidelines for diagnosis and management of osteoporosis in Canada/J.P. Brown, R.G. Josse//CMAJ. -2002. -Vol. 10, N 167, Suppl. -P. S1-S34.

[7]

7. Cramer J.A. Complinance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis/J.A. Cramer, M.M. Amonkar, A. Hebborn, R. Altman//Curr. Med. Res. Opin. -2005. -N21. -P. 1453-1460.

[8]

8. Lyles K.W. Zoledronic acid in reducing clinical fracture and mortality after hip fracture/K.W. Lyles [et al.]//New Engl. J. Med. -2007. -P. 357.

[9]

9. Melton L.J. III Vertebral fractures predict subsequent fractures/L.J. Melton III [et al.]//Osteoporos. Int. -1999. -N 10. -P. 214-221.

AI Summary AI Mindmap
PDF

148

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/